http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0766544-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86efdc91ff3f68176c4ff1266f15038a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1995-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfca2a760a1eff2875406255e83b597e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b51c12f9e6fc13eaf27d0ed6cd221ba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81cec8a8aa3f62168531075c0d445484
publicationDate 1998-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0766544-B1
titleOfInvention Sclerotomy implant
abstract PCT No. PCT/FR95/00818 Sec. 371 Date Dec. 11, 1996 Sec. 102(e) Date Dec. 11, 1996 PCT Filed Jun. 20, 1995 PCT Pub. No. WO95/35078 PCT Pub. Date Dec. 28, 1995A sclerotomy implant intended to be set in place in the sclera of the eye in order to provide for a continuous flow of aqueous humor through the trabecula for the treatment of a glaucoma. This implant is configured like a platelet made of biocompatible material and comprising an intrascleral portion (1) and a sub-conjuctival portion (5), the latter being adapted to come out of the sclera and penetrate under the conjunctiva. Retaining flanges (7a, 7b) provide for the blocking of the implant in the trap under the scleral flap. The implant comprises at least one continuous flow passage from its trabecular extremity (2) applied against the trabecula up to its external extremity (6) inserted in the conjunctiva.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464675-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11540940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2721299-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537474-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10492949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9693899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9931243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9693902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709547-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10687978-B2
priorityDate 1994-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66587478

Total number of triples: 37.